UK News and communications,Sugemalimab approved to treat adult patients with non-small cell lung cancer
Sugemalimab Approved to Treat Adult Patients with Non-Small Cell Lung Cancer London, UK – October 30, 2024 – UK News and Communications reports that Sugemalimab, a PD-1 monoclonal antibody, has been approved by the National Institute for Health and Care Excellence (NICE) for the treatment of adult patients with locally advanced or metastatic non-small cell … Read more